VIDAS TBI
Commercial- Indications
- Traumatic brain injury
Company intelligence / Profile preview
bioMérieux
Marcy-l'Étoile, Auvergne-Rhône-Alpes, Francebiomerieux.com ↗
- Ownership
- Public · BIM
- Employees
- ~13000
- Development stage
- Commercial
01
Overview
bioMérieux’s diagnostic products are widely adopted globally in clinical microbiology labs and hospitals. Their systems are validated by regulatory agencies including FDA clearance for several platforms. The company continues to launch new products addressing rapid pathogen detection and antimicrobial resistance with strong commercial performance worldwide.
- Therapeutic areas
- OtherOncologyCardiovascularInfectious Diseases
- Modalities
- DeviceDiagnostic reagentSoftware
- Industry
- Molecular Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Quanterix – development of ultrasensitive multiplex immunoassaysOxford Nanopore – investment partnership on nanopore-based molecular sensing technologyDay Zero Diagnostics – acquisition agreement for genome sequencing/machine learning infectious disease diagnostics assets
04
Financials
- Market cap
- $17.1B
- Total revenue
- $9.7B
- Enterprise value
- $24.8B
Beyond the preview
Go deeper on bioMérieux.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bioMérieux.